Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Agri ; 28(1): 9-17, 2016 Jan.
Artigo em Turco | MEDLINE | ID: mdl-27225607

RESUMO

OBJECTIVES: The aim of the present study was to compare preventive effects of 10% povidone-iodine, and combination of 2-propanol and benzalkonium chloride skin antiseptics on contamination of epidural catheter tip. METHODS: Included were 160 patients aged 18-65 years with American Society of Anesthesiologists (ASA) physical status classifications of I-II. Patients were randomized. Povidone-iodine was administered to group P (n=80) prior to insertion of antibiotic prophylaxis catheter; 2-propanol and benzalkonium chloride was administered to group B. Swabs obtained before and after administration of antiseptics were sent for culture. Antiseptics were applied to skin prior to catheter removal, as well as 48 hours after insertion. In sterile conditions, 2-3 cm pieces of catheter tips were sent to laboratory. Preoperative and postoperative complete blood count, body temperature, and signs of postoperative localized skin infection were recorded. RESULTS: Leukocyte, neutrophil, and lymphocyte counts were all within normal ranges in preoperative and postoperative. Swab cultures obtained following use of antiseptics were positive in 6 group P patients; coagulase-negative Staphylococcus was found in 5 patients, E. coli in 1, and were negative in group B. Difference between groups was statistically significant (p=0.013). Epidural catheter tip cultures were negative. CONCLUSION: Combination of 2-propanol and benzalkonium chloride was determined to be more effective in reducing skin flora around epidural catheter insertion site.


Assuntos
Anti-Infecciosos Locais/administração & dosagem , Compostos de Benzalcônio/administração & dosagem , Povidona-Iodo/administração & dosagem , Infecção da Ferida Cirúrgica/prevenção & controle , 2-Propanol/administração & dosagem , Administração Cutânea , Adolescente , Adulto , Idoso , Analgesia Epidural , Cateterismo Periférico , Desinfecção , Contaminação de Equipamentos/prevenção & controle , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento , Adulto Jovem
2.
J ECT ; 30(1): 30-4, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23812022

RESUMO

BACKGROUND: We aimed to compare the effects of succinylcholine and rocuronium-sugammadex on development of myalgia and headache after electroconvulsive therapy (ECT). METHODS: Forty-five patients undergoing ECT were enrolled in the study. Anesthesia induction was provided with propofol 1 mg/kg intravenously (IV) + succinylcholine 1 mg/kg IV in group S (n = 24) and propofol 1 mg/kg IV + rocuronium 0.3 mg/kg IV in group R (n = 21). Sugammadex 4 mg/kg IV was administered to group R after the motor seizure. The first 3 ECT sessions were evaluated on the basis of time to onset of spontaneous respiration following the induction, time to eye-opening response to verbal stimuli, and visual analog scale (VAS) scores for myalgia and headache at hours 2, 6, 12, and 24 following the ECT for all patients. RESULTS: The times to onset of spontaneous respiration and eye-opening response to verbal stimuli were significantly shorter in all the 3 sessions in group R compared with group S (P < 0.002). Myalgia VAS scores at hours 2, 6, and 12 and the headache VAS scores at hours 2 and 6 were significantly higher in group S versus group R (P < 0,015). CONCLUSIONS: We concluded that the rates of myalgia and headache after ECT were significantly lower in group R than in group S, and also the awakening time (spontaneous respiration and opening the eyes in response to verbal stimuli) was significantly shorter in group R compared with group S.


Assuntos
Androstanóis/uso terapêutico , Transtorno Depressivo Maior/complicações , Transtorno Depressivo Maior/terapia , Eletroconvulsoterapia/efeitos adversos , Cefaleia/etiologia , Cefaleia/prevenção & controle , Mialgia/etiologia , Mialgia/prevenção & controle , Fármacos Neuromusculares não Despolarizantes/uso terapêutico , gama-Ciclodextrinas/uso terapêutico , Adulto , Idoso , Anestesia , Período de Recuperação da Anestesia , Feminino , Cefaleia/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Mialgia/epidemiologia , Fármacos Neuromusculares Despolarizantes , Medição da Dor , Rocurônio , Tamanho da Amostra , Convulsões/fisiopatologia , Succinilcolina , Sugammadex
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA